Galectin Therapeutics Inc.

• Galectin Therapeutics Inc. Estimates – NASDAQ:GALT
  TradingView · 23 Oct 2026
• MarketBeat cites USD 11.00 target for Galectin Therapeutics stock
  AD HOC NEWS · 20 Oct 2026
• Galectin Therapeutics stock has November 13 earnings, USD -0.05 estimate
  AD HOC NEWS · 17 Oct 2026
• Galectin Therapeutics (NASDAQ:GALT) Stock Price Breaks Above 200 Day Moving Average - Here's Why
  MarketBeat · 16 Oct 2026
• GALECTIN THERAPEUTICS INC SEC Filing (Oct 13, 2026)
  Stock Titan · 13 Oct 2026
• Galectin Therapeutics (NASDAQ:GALT) Shares Cross Above Two Hundred Day Moving Average - Here's Why
  MarketBeat · 08 Oct 2026
• Galectin: $105M Debt Conversion Clears The Balance Sheet, But Phase 3 Partnership Is Critical
  Seeking Alpha · 06 Oct 2026
• Galectin Therapeutics (NASDAQ:GALT) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell?
  MarketBeat · 30 Sep 2026
• Galectin Therapeutics stock falls 2.22 percent as trial advances
  ad-hoc-news.de · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →